Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy

Abstract Background Persistence of β cell-function in Type 1 diabetes (T1D) is associated with glycaemia stability and lower prevalence of microvascular complications. We aimed to assess the prevalence of residual C- peptide secretion in long-term Brazilian childhood onset T1D receiving usual diabet...

Full description

Bibliographic Details
Main Authors: Monica A. L. Gabbay, Felipe Crispim, Sergio A. Dib
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-023-01014-z
_version_ 1797863997463068672
author Monica A. L. Gabbay
Felipe Crispim
Sergio A. Dib
author_facet Monica A. L. Gabbay
Felipe Crispim
Sergio A. Dib
author_sort Monica A. L. Gabbay
collection DOAJ
description Abstract Background Persistence of β cell-function in Type 1 diabetes (T1D) is associated with glycaemia stability and lower prevalence of microvascular complications. We aimed to assess the prevalence of residual C- peptide secretion in long-term Brazilian childhood onset T1D receiving usual diabetes care and its association to clinical, metabolic variables and microvascular complications. Methods A cross-sectional observational study with 138 T1D adults with ≥ 3 years from the diagnosis by routine diabetes care. Clinical, metabolic variables and microvascular complications were compared between positive ultra-sensitive fasting serum C-peptide (FCP +) and negative (FCP-) participants. Results T1D studied had ≥ 3 yrs. of diagnosis and 60% had FCP > 1.15 pmol/L. FCP + T1D were older at diagnosis (10 vs 8 y.o; p = 0.03) and had less duration of diabetes (11 vs 15 y.o; p = 0.002). There was no association between the FCP + and other clinical and metabolic variable but there was inversely association with microalbuminuria (28.6% vs 13.4%, p = 0.03), regardless of HbA1c. FCP > 47 pmol/L were associated with nephropathy protection but were not related to others microvascular complications. Conclusion Residual insulin secretion is present in 60% of T1D with ≥ 3 years of diagnosis in routine diabetes care. FCP + was positively associated with age of diagnosis and negatively with duration of disease and microalbuminuria, regardless of HbA1c.
first_indexed 2024-04-09T22:44:29Z
format Article
id doaj.art-15400a7e2dd347af9ae8be8321a5128d
institution Directory Open Access Journal
issn 1758-5996
language English
last_indexed 2024-04-09T22:44:29Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj.art-15400a7e2dd347af9ae8be8321a5128d2023-03-22T11:55:59ZengBMCDiabetology & Metabolic Syndrome1758-59962023-03-011511710.1186/s13098-023-01014-zResidual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathyMonica A. L. Gabbay0Felipe Crispim1Sergio A. Dib2Centre for Diabetes, Endocrinology Division, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São PauloMolecular Biology Laboratory, Endocrinology Division, Department of Medicine Escola Paulista de Medicina, Universidade Federal de São PauloCentre for Diabetes, Endocrinology Division, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São PauloAbstract Background Persistence of β cell-function in Type 1 diabetes (T1D) is associated with glycaemia stability and lower prevalence of microvascular complications. We aimed to assess the prevalence of residual C- peptide secretion in long-term Brazilian childhood onset T1D receiving usual diabetes care and its association to clinical, metabolic variables and microvascular complications. Methods A cross-sectional observational study with 138 T1D adults with ≥ 3 years from the diagnosis by routine diabetes care. Clinical, metabolic variables and microvascular complications were compared between positive ultra-sensitive fasting serum C-peptide (FCP +) and negative (FCP-) participants. Results T1D studied had ≥ 3 yrs. of diagnosis and 60% had FCP > 1.15 pmol/L. FCP + T1D were older at diagnosis (10 vs 8 y.o; p = 0.03) and had less duration of diabetes (11 vs 15 y.o; p = 0.002). There was no association between the FCP + and other clinical and metabolic variable but there was inversely association with microalbuminuria (28.6% vs 13.4%, p = 0.03), regardless of HbA1c. FCP > 47 pmol/L were associated with nephropathy protection but were not related to others microvascular complications. Conclusion Residual insulin secretion is present in 60% of T1D with ≥ 3 years of diagnosis in routine diabetes care. FCP + was positively associated with age of diagnosis and negatively with duration of disease and microalbuminuria, regardless of HbA1c.https://doi.org/10.1186/s13098-023-01014-zC-peptideType 1 diabetesMicrovascular complications
spellingShingle Monica A. L. Gabbay
Felipe Crispim
Sergio A. Dib
Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy
Diabetology & Metabolic Syndrome
C-peptide
Type 1 diabetes
Microvascular complications
title Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy
title_full Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy
title_fullStr Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy
title_full_unstemmed Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy
title_short Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy
title_sort residual β cell function in brazilian type 1 diabetes after 3 years of diagnosis prevalence and association with low presence of nephropathy
topic C-peptide
Type 1 diabetes
Microvascular complications
url https://doi.org/10.1186/s13098-023-01014-z
work_keys_str_mv AT monicaalgabbay residualbcellfunctioninbraziliantype1diabetesafter3yearsofdiagnosisprevalenceandassociationwithlowpresenceofnephropathy
AT felipecrispim residualbcellfunctioninbraziliantype1diabetesafter3yearsofdiagnosisprevalenceandassociationwithlowpresenceofnephropathy
AT sergioadib residualbcellfunctioninbraziliantype1diabetesafter3yearsofdiagnosisprevalenceandassociationwithlowpresenceofnephropathy